SERES is hiring, find jobs on Simplify. Start your career today.

We update SERES's jobs every 8 hours, so check again soon!

SERES

SERES

Develops microbiome therapeutics for serious diseases

Biotechnology

Work Here? Claim Your Company

Company Overview
Seres Therapeutics stands out as a pioneering force in the biotech industry, being the first to gain FDA approval for an orally administered microbiota-based therapeutic, VOWST™, to prevent recurrence of C. difficile infection. The company's culture is deeply rooted in scientific exploration and collaboration, as evidenced by their partnership with Nestlé Health Science and ongoing research in areas such as gastrointestinal infections and ulcerative colitis. Their commitment to transforming patient lives through advanced microbiome therapeutics positions them as a leader in their field, offering employees the opportunity to contribute to groundbreaking work in a supportive, forward-thinking environment.
Biotechnology

Company Stage

N/A

Total Funding

$489.8M

Founded

2010

Headquarters

Cambridge, Massachusetts

Growth & Insights
Headcount

6 month growth

-25%

1 year growth

-25%

2 year growth

-5%